11,12 And 14,15 Epoxyeicosatrienoic Acid Rescue Deteriorated Wound Healing In Ischemia

IntroductionEpoxyeicosatrienoic acids (EETs) are able to enhance angiogenesis and regulate inflammation that is especially important in wound healing under ischemic conditions. Thus, we evaluated the effect of local EET application on ischemic wounds in mice.MethodsIschemia was induced by cautherization of two of the three supplying vessels to the mouse ear. Wounding was performed on the ear three days later. Wounds were treated either with 11,12 or 14,15 EET and compared to untreated control and normal wounds. Epithelialization was measured every second day. VEGF, TNF-alpha, TGF-beta, matrix metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP), Ki67, and SDF-1 alpha were evaluated immuno-histochemically in wounds on day 3, 6, and 9.ResultsIschemia delayed wound closure (12.8 days +/- 1.9 standard deviation (SD) for ischemia and 8.0 days +/- 0.94 SD for control). 11,12 and14,15 EET application ameliorated deteriorated wound healing on ischemic ears (7.6 +/- 1.3 SD for 11,12 EET and 9.2 +/- 1.4 SD for 14,15 EET). Ischemia did not change VEGF, TNF-alpha, TGF-beta, SDF-1 alpha, TIMP, MMP7 or MMP9 level significantly compared to control. Local application of 11,12 as well as 14,15 EET induced a significant elevation of VEGF, TGF-beta, and SDF-1 alpha expression as well as proliferation during the whole phase of wound healing compared to control and ischemia alone.ConclusionIn summary, EET improve impaired wound healing caused by ischemia as they enhance neovascularization and alter inflammatory response in wounds. Thus elevating lipid mediator level as 11,12 and 14,15 EET in wounds might be a successful strategy for amelioration of deranged wound healing under ischemia.